ABP – abpro holdings, inc (US:NASDAQ)
Stock Stats
News
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 [Yahoo! Finance]
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Abpro Holdings, Inc. For: Jan 06
Form 8-K Abpro Holdings, Inc. For: Dec 15
Form 8-K Abpro Holdings, Inc. For: Dec 09
Form EFFECT Abpro Holdings, Inc.
Form S-1/A Abpro Holdings, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.